5466-43-3

基本信息
2,4-二氯-5,6-三甲基嘧啶
2,4-二氯-5,6-三亞甲基嘧啶
2,4-二氯-6,7-二氫-5H-環(huán)戊[D]嘧啶
2,4-二氯-6,7-二氫-5H-環(huán)戊并[D]嘧啶
2,4-二氫-6,7-二氫-5H-環(huán)戊基并[D]嘧啶
2,4-二氯-6,7-二氫-5H-環(huán)戊烷并[D]嘧啶
2,4-二氯-6,7-二氫-5H-環(huán)戊烯并[D]嘧啶
4-dichloro-6
7-dihydro-5H-cyclopenta[d]pyriMidine
2,4-Dichloro-5,6-trimethylenepyrimidine
2,4-Dichloro-5H,6H,7H-cyclopenta[d]pyrimidine
2,4-DICHLORO-6,7-DIHYDRO-5H-CYCLOPENTAPYRIMIDINE
5H-Cyclopentapyrimidine, 2,4-dichloro-6,7-dihydro-
2,4-dichloro-6,7-dihydro-1H-cyclopenta[d]pyrimidine
2,4-dichloro-6,7-dihydro-5H-cyclopenta[d][1,3]chlorazine
2,4-DICHLORO-6,7-DIHYDRO-5H-CYCLOPENTAPYRIMIDINE ISO 9001:2015 REACH
物理化學(xué)性質(zhì)
制備方法
![6,7-二氫-1H-環(huán)戊并[D]嘧啶-2,4(3H,5H)-二酮](/CAS/GIF/5466-00-2.gif)
5466-00-2

5466-43-3
以6,7-二氫-1H-環(huán)戊并[d]嘧啶-2,4(3H,5H)-二酮為原料合成2,4-二氯-5,6-三甲基嘧啶的一般步驟:將6,7-二氫-1H-環(huán)戊并[d]嘧啶-2,4(3H,5H)-二酮(0.3g,1.97mmol)懸浮于磷酰氯(5ml)中,加熱回流過夜。反應(yīng)完成后,將反應(yīng)混合物冷卻至室溫,隨后在冰浴條件下緩慢加入水。過濾收集沉淀的產(chǎn)物,干燥后得到黃色固體2,4-二氯-5,6-三甲基嘧啶。產(chǎn)率:92%。1H NMR(DMSO-d6,300MHz):δ 3.13(t,2H,環(huán)戊基-CH2),3.00(t,2H,環(huán)戊基-CH2),2.23(m,2H,環(huán)戊基-CH2)。
參考文獻(xiàn):
[1] European Journal of Medicinal Chemistry, 1980, vol. 15, # 4, p. 317 - 322
[2] European Journal of Medicinal Chemistry, 2015, vol. 92, p. 246 - 256
[3] Patent: US2010/144731, 2010, A1. Location in patent: Page/Page column 22
[4] Patent: US2007/281949, 2007, A1. Location in patent: Page/Page column 93-94
[5] Patent: US2014/179668, 2014, A1. Location in patent: Paragraph 0829